$24.14

-1.11 (-4.40%)

10/10/2008 4:18 PM

Health Care SPDR (ETF) (XLV)

CAPS Rating:

Seeks to replicate the total return of the Consumer Services Select Sector of the S&P 500 Index. It unbundles the benchmark S&P 500 and gives the investor ownership in particular sectors of industries represented by a specified Select Sector Index.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating XLV

Add Stock to Watchlist

What the Community Thinks

Total Members

52 Outperforms

4 Underperforms

All-Stars

18 Outperforms

0 Underperforms

Members bullish on XLV are also bullish on:

Members bearish on XLV are also bearish on:

Ticker Tags

Closed-End Fund - Equity (269), Small Cap (1922), ETF (Exchange Traded Fund or Note) (967)
Suggest a tag

Health Care SPDR (ETF) At A Glance

Current Price:	$24.14
Last Trade Time:	10/10/2008 4:18 PM
Open:	$24.10
Previous Close:	$25.25
Daily Range:	$22.89 - $25.54
52-Week Range:	$25.00 - $37.89
Volume:	15,960,722
Market Cap:	$2.33B
P/E Ratio:	0.00
Compare Our Special Broker Offers!

Stock Trends

XLV VS S&P 500 (SPY)

News & Discussion Boards

Sorry no news articles available for XLV.

Top Bull Pitch

Recs

5 Health Care SPDR (ETF) (XLV)

Avatar xthecritic (66.85) Submitted: 2/06/08 1:58 PM

Favorable demographics for healthcare over the next decade. The presidential election is a bit of a wild card in this sector but I am comfortable taking that risk. With the market turmoil, outperforms on defensive ETFs are a good bet regardless.

-- Profit of Portsmouth

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1 Health Care SPDR (ETF) (XLV)

Avatar NetscribeETF (28.64) Submitted: 2/01/07 6:44 AM

The health-care market already tops $2 trillion and driven by aging baby boomers in the U.S. its expansion continues, without getting affected by the ups and downs of the overall economy. Though the market looks sound, most of the stocks in the sector are in a strong uptrend and due for correction, ...More

Replies: 0 | Reply | Permalink

CAPS Members

Show Me:

Sort by:

picks per page. CHANGE

Results 1 - 5 of 7 : 1 2 Next »

Recs 0 (XLV) InvestRx (95.91) Submitted: 10/07/08 4:55 PM : Start Price: $28.50 XLV Score: 0.15 Despite concerns over the health of the domestic economy along with surging food and energy prices, the healthcare sector has failed to garner investor interest as a safe haven. Most healthcare exchange-traded funds [ETFs] and drug stocks continue to languish near multi-year lows, despite an aging Baby Boomer population and ever-increasing proportion of the gross domestic product [GDP] accounted for by healthcare spending. Last year, total health expenses grew at twice the inflation rate (6.9%), accounting for 16% of the GDP at $2.3 trillion. This growth rate is expected to continue over the next decade to a level of $4.2 trillion in 2016, accounting for 20% of the GDP, based on statistics provided by the National Coalition for Health Care website. Two popular ETFs that provide investors with diversified exposure to the healthcare sectoraree the State Street Healthcare SPDR (XLV) and iShares S&P Global Healthcare (IXJ). I prefer the latter, based on its exposure to companies based outside of the United States and total number of holdings at 79, which is about 50% more than the stock holdings of XLV. The top 10 holdings for XLV account for about 53% of the assets, with the majority of these positions invested in US-based big pharma companies. IXJ provides a more balanced top 10 holdings list that accounts for about 50% of assets and is divided evenly between US-based and European big pharma and diversified healthcare giants. The top three holdings in XLV include Johnson & Johnson (JNJ) (13.9%), Pfizer (PFE) (9.9%), and Merck (MRK) (6.0%) versus IXJ which holds Johnson & Johnson (8.9%), Novartis (NVS) (6.6%), and Pfizer (6.1%). Despite the fact that XLV has attracted about fourfold more net assets and has a much higher trading volume, IXJ should not present any liquidity concerns given that its average daily trading volume is over 50,000 shares with over $600 million in net assets. IXJ has outperformed XLV for all of the timeframes outlined in this chart except for the two-year return, and I believe the geographical diversification and access to foreign-listed companies will continue the performance trends in favor of IXJ. Although the big pharma and diversified healthcare mega-caps in both of these funds have global reach and operations, the foreign players have the distinct advantage of proximity and opportunities to provide healthcare products and services to growing frontier and emerging markets in Eastern Europe, the Middle East, and throughout Asia. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (XLV) Telehound (< 20) Submitted: 9/24/08 9:18 PM : Start Price: $30.73 XLV Score: 5.28 Lots of folks are growing older! Baby Boomers with healthy retirement accounts and benefits- someone will need to take care of them and healthcare companies will jump on this opportunity to cash in on revenue. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (XLV) ericyoung06 (56.76) Submitted: 8/06/08 10:51 PM : Start Price: $32.64 XLV Score: 4.80 I like Health Care right now. Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 5 (XLV) xthecritic (66.85) Submitted: 2/06/08 1:58 PM : Start Price: $33.45 XLV Score: 6.93 Favorable demographics for healthcare over the next decade. The presidential election is a bit of a wild card in this sector but I am comfortable taking that risk. With the market turmoil, outperforms on defensive ETFs are a good bet regardless. -- Profit of Portsmouth Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out. Recs 0 (XLV) 5675050 (79.47) Submitted: 8/19/07 10:06 AM : Start Price: $33.78 XLV Score: 10.51 defansive ETF Report this Post Replies: 0 \| Reply \| Permalink Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Results 1 - 5 of 7 : 1 2 Next »

Wall Street

There are no Wall Street tracker picks.

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.